FR2183751B1 - - Google Patents

Info

Publication number
FR2183751B1
FR2183751B1 FR7315861A FR7315861A FR2183751B1 FR 2183751 B1 FR2183751 B1 FR 2183751B1 FR 7315861 A FR7315861 A FR 7315861A FR 7315861 A FR7315861 A FR 7315861A FR 2183751 B1 FR2183751 B1 FR 2183751B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7315861A
Other languages
French (fr)
Other versions
FR2183751A1 (US20030220297A1-20031127-C00074.png
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme IA Corp
Merck Sharp and Dohme Corp
Original Assignee
Merck Sharp and Dohme IA Corp
Merck Sharp and Dohme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp and Dohme IA Corp, Merck Sharp and Dohme Corp filed Critical Merck Sharp and Dohme IA Corp
Publication of FR2183751A1 publication Critical patent/FR2183751A1/fr
Application granted granted Critical
Publication of FR2183751B1 publication Critical patent/FR2183751B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • C07D231/20One oxygen atom attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • C07D231/20One oxygen atom attached in position 3 or 5
    • C07D231/22One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/28Two oxygen or sulfur atoms
    • C07D231/30Two oxygen or sulfur atoms attached in positions 3 and 5
    • C07D231/32Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR7315861A 1972-05-05 1973-05-03 Expired FR2183751B1 (US20030220297A1-20031127-C00074.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA141470A CA1001161A (en) 1972-05-05 1972-05-05 5-(3-substituted amino-2-hydroxypropoxy)1,3-disubstituted pyrazoles and method of preparation

Publications (2)

Publication Number Publication Date
FR2183751A1 FR2183751A1 (US20030220297A1-20031127-C00074.png) 1973-12-21
FR2183751B1 true FR2183751B1 (US20030220297A1-20031127-C00074.png) 1976-10-22

Family

ID=4093188

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7315861A Expired FR2183751B1 (US20030220297A1-20031127-C00074.png) 1972-05-05 1973-05-03

Country Status (14)

Country Link
US (1) US3920691A (US20030220297A1-20031127-C00074.png)
JP (1) JPS4947367A (US20030220297A1-20031127-C00074.png)
AU (1) AU474793B2 (US20030220297A1-20031127-C00074.png)
BE (1) BE799098A (US20030220297A1-20031127-C00074.png)
CA (1) CA1001161A (US20030220297A1-20031127-C00074.png)
CH (1) CH582677A5 (US20030220297A1-20031127-C00074.png)
DE (1) DE2322313A1 (US20030220297A1-20031127-C00074.png)
ES (1) ES414320A1 (US20030220297A1-20031127-C00074.png)
FR (1) FR2183751B1 (US20030220297A1-20031127-C00074.png)
GB (1) GB1390485A (US20030220297A1-20031127-C00074.png)
HU (1) HU165583B (US20030220297A1-20031127-C00074.png)
NL (1) NL7305477A (US20030220297A1-20031127-C00074.png)
SE (1) SE400076B (US20030220297A1-20031127-C00074.png)
ZA (1) ZA733049B (US20030220297A1-20031127-C00074.png)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2619164C2 (de) * 1976-04-30 1985-07-11 Boehringer Mannheim Gmbh, 6800 Mannheim Indazolyl-(4)-oxy-propanolamine, Verfahren zu ihrer Herstellung und deren Verwendung
FI57617C (fi) * 1979-01-18 1980-09-10 Viljanmaa Antti Spaennanordning foer skinn
DE2926517A1 (de) * 1979-06-30 1981-01-15 Beiersdorf Ag Substituierte 3-aryl-pyrazole und 5-aryl-isoxazole und verfahren zu ihrer herstellung
US5547967A (en) * 1993-12-08 1996-08-20 Kali-Chemie Pharma Gmbh (Phenylalkylaminoalkyloxy)-heteroaryl-compounds, processes and intermediates for their production and pharmaceutical compositions containing them
DE4341749A1 (de) * 1993-12-08 1995-06-14 Kali Chemie Pharma Gmbh 3-(Phenylalkylaminoalkyloxy)-5-phenylpyrazol- Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
WO1999029672A1 (en) * 1997-12-05 1999-06-17 Eli Lilly And Company SELECTIVE β3 ADRENERGIC AGONISTS
CO5011072A1 (es) 1997-12-05 2001-02-28 Lilly Co Eli Etanolaminas pirazinil substituidas como agfonistas de los receptores

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1201061A (en) * 1966-08-26 1970-08-05 Endo Lab Oxo pyrroles and process for preparing same
US3629433A (en) * 1968-09-16 1971-12-21 Ciba Geigy Corp Antidepressant compositions of cycloalkano(c)pyrazole ethers
US3637738A (en) * 1969-02-12 1972-01-25 Ciba Geigy Corp Cycloalkano(c)pyrazole ethers
US3726896A (en) * 1970-05-06 1973-04-10 Szabo Hnos Kessler & Cia 1-benzyl-3(2,3-dihydroxypropoxy)indazole

Also Published As

Publication number Publication date
AU5493773A (en) 1974-10-31
SE400076B (sv) 1978-03-13
HU165583B (US20030220297A1-20031127-C00074.png) 1974-09-28
CA1001161A (en) 1976-12-07
AU474793B2 (en) 1976-08-05
ZA733049B (en) 1974-12-24
NL7305477A (US20030220297A1-20031127-C00074.png) 1973-11-07
ES414320A1 (es) 1976-02-01
US3920691A (en) 1975-11-18
DE2322313A1 (de) 1973-11-22
FR2183751A1 (US20030220297A1-20031127-C00074.png) 1973-12-21
JPS4947367A (US20030220297A1-20031127-C00074.png) 1974-05-08
BE799098A (fr) 1973-11-05
GB1390485A (en) 1975-04-16
CH582677A5 (US20030220297A1-20031127-C00074.png) 1976-12-15

Similar Documents

Publication Publication Date Title
FR2183751B1 (US20030220297A1-20031127-C00074.png)
FR2174301A1 (US20030220297A1-20031127-C00074.png)
JPS5414768B2 (US20030220297A1-20031127-C00074.png)
JPS4899420A (US20030220297A1-20031127-C00074.png)
CH567915A5 (US20030220297A1-20031127-C00074.png)
CH565866A5 (US20030220297A1-20031127-C00074.png)
CH576935A5 (US20030220297A1-20031127-C00074.png)
CH576520A5 (US20030220297A1-20031127-C00074.png)
CH572817A5 (US20030220297A1-20031127-C00074.png)
CH572668A5 (US20030220297A1-20031127-C00074.png)
CH570018A5 (US20030220297A1-20031127-C00074.png)
CH580289A5 (US20030220297A1-20031127-C00074.png)
CH569327A5 (US20030220297A1-20031127-C00074.png)
CH580737A5 (US20030220297A1-20031127-C00074.png)
CH569310A5 (US20030220297A1-20031127-C00074.png)
CH582683A5 (US20030220297A1-20031127-C00074.png)
CH583039A5 (US20030220297A1-20031127-C00074.png)
CH569299A5 (US20030220297A1-20031127-C00074.png)
CH568241A5 (US20030220297A1-20031127-C00074.png)
CH578307A5 (US20030220297A1-20031127-C00074.png)
CH567850A5 (US20030220297A1-20031127-C00074.png)
CH567507A5 (US20030220297A1-20031127-C00074.png)
CH583247A5 (US20030220297A1-20031127-C00074.png)
CH577744A5 (US20030220297A1-20031127-C00074.png)
CH564727A5 (US20030220297A1-20031127-C00074.png)

Legal Events

Date Code Title Description
ST Notification of lapse